Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1989
11/23/1989EP0342524A1 Medicine for treating mycotic, microbial and other tissue damaging and pathological manifestations and deformations of tissue
11/21/1989US4882435 Pharmaceutical preparations
11/21/1989US4882164 Parenteral micelle solutions
11/21/1989CA1263086A1 Method for producing oncolysis
11/16/1989WO1989010758A1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/16/1989WO1989010744A1 Neurologically active compounds
11/15/1989EP0341624A2 Method of effecting immunosuppression
11/15/1989EP0341559A2 Synergistic mixtures and their therapeutical use
11/15/1989EP0341558A2 Use and agent for diminishing the secondary effects of TNF
11/15/1989EP0341264A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
11/15/1989EP0341261A1 Anti-smoking agent
11/14/1989US4880742 Prostaglandin biosynthesis inhibitors
11/14/1989US4880635 Dehydrated liposomes
11/14/1989US4880626 Immunology, vaccines
11/08/1989EP0340270A1 5-ht 3? receptor antagonists for treatment of cough and bronchoconstriction
11/07/1989US4879298 Administering forskoline to potentiate analgesic effects of narcotics
11/07/1989US4879285 Fertility control
11/07/1989US4879109 Method for treating burns
11/07/1989EP0260312A4 Method for blocking calcium channels.
11/02/1989WO1989010143A1 Certain paf antagonist antihistamine combinations and methods
11/02/1989WO1989010140A1 Further improvements relating to drug delivery systems
11/02/1989WO1989010136A1 Prophylactic and therapeutic methods for treating edema with phallotoxins
11/02/1989WO1989010134A1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier
11/02/1989WO1989010129A1 Pharmaceutical composition containing deoxyribonucleosides for wound healing
11/02/1989WO1989010126A1 Antiglaucoma compositions containing combinations of alpha-2 agonists and beta-blockers
11/02/1989WO1989010125A1 Method of reversing the side effects of epidural analgesics
11/02/1989WO1989010120A1 Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers
11/02/1989EP0340008A1 Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
11/02/1989EP0339905A2 Wound healing compositions containing growth factors and retinoids
11/02/1989EP0339101A1 Agent for influencing the blood sugar level at diabetes
11/02/1989EP0339075A1 Acylated uridine and cytidine and uses thereof
10/1989
10/31/1989US4877883 Substituted pyrazoles
10/31/1989US4877619 Liposomal vesicles for intraperitoneal administration of therapeutic agents
10/25/1989EP0338745A1 Method for producing recombinant DNA proteins
10/25/1989EP0338679A2 Tumour necrosis factor in the treatment of bladder cancer
10/25/1989EP0338532A2 N-alkylamino derivates of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
10/25/1989EP0338395A2 Monoclonal antibodies to Pseudomonas aeruginosa, their production and use
10/25/1989EP0299975A4 Composition for arresting angiogenesis and capillary, cell or membrane leakage.
10/24/1989US4876283 Antisnoring agent
10/19/1989WO1989009833A1 Luminide and macroluminide class of pharmaceuticals
10/19/1989WO1989009825A1 Method for producing recombinant dna proteins
10/19/1989WO1989009817A1 Composition and method for acceleration of clot lysis
10/19/1989WO1989009800A1 Novel transdermal penetration enhancers
10/19/1989WO1989009620A1 Drug for treating cancer, aids and viral diseases
10/19/1989WO1989009600A1 Method and composition for treating neurological disorders
10/18/1989EP0337739A2 Use of TP-receptor antagonists to modify the action of myofibroblasts
10/18/1989EP0337697A2 Use of a thromboxane A2 receptor antagonist for the manufacture of a medicament for treating pulmonary hypertension caused by protamine induced neutralization of hepamin
10/18/1989EP0336950A1 Potentiation of antihypertensive effect of ace inhibitors
10/17/1989US4874850 Pharmaceutical preparations
10/17/1989CA1262335A1 Hair growth modification
10/11/1989EP0336731A2 Method of amplifying and detecting nucleic acid sequences
10/11/1989EP0336693A2 Acceleration of clot lysis
10/11/1989EP0336631A2 Improved cytotoxic therapy
10/11/1989EP0335966A1 Vasoconstrictive substances in combination with cytotoxic agents
10/10/1989US4873190 Heterodimeric T lymphocyte receptor
10/10/1989US4873081 Percutaneous absorption preparation
10/10/1989US4873076 Method of safely providing anesthesia or conscious sedation
10/05/1989WO1989009061A1 Improved cytotoxic therapy
10/04/1989EP0335442A2 Agents for preserving or restoring the soundness of the skin
10/04/1989EP0335133A2 Drug delivery using pulmonary surfactant fo facilitate absorption
10/03/1989US4871742 Administering allopurinol, oxypurinol, or flavonoid
10/03/1989US4871733 Cough/cold mixtures comprising non-sedating antihistamine drugs
09/1989
09/27/1989EP0334576A2 Intraperitoneal treatment by chemotherapeutic agent and non-steroidal antiinflammatory drug
09/27/1989EP0334300A1 The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites
09/27/1989EP0334264A2 Pharmaceutical compositions for treating tardive dyskinesia employing an ace inhibitor
09/27/1989EP0333769A1 Combinations of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents for treating diseases
09/26/1989US4870174 Imidozopyrionidines and their use in pharmaceutical preparations
09/26/1989US4870067 Oxytocins and antigestagens in combination for induction of birth
09/26/1989US4870053 Antiallergy acyl glycoprotein from klebsiella
09/26/1989CA1262005A1 Polymer, production and use thereof
09/26/1989CA1261752A1 Antidiarrheal compositions and use thereof
09/26/1989CA1261262A1 Method of inducing labour or terminating a pregnancy using a prostaglandin and an antigestagen and packs and preparations suitable therefor
09/26/1989CA1260829A1 Drug delivery system
09/26/1989CA1259920A1 Immunotoxin and method of making
09/21/1989WO1989008449A1 Method of potentiating an immune response and composition therefor
09/21/1989WO1989008446A1 Suspended-release preparation prepared by using alginic acid
09/21/1989WO1989007656A3 Clinical testing, monitoring and pharmaceutical compositions for treatment of auto-immune diseases
09/20/1989EP0333523A2 Method of potentiating an immune response and compositions therefor
09/20/1989EP0332952A2 Polysulfated heparin combinations against retrovirus infections
09/20/1989EP0332918A2 Compositions containing a calcium antagonist and a lipid-lowering agent
09/20/1989EP0332657A1 Antimalarial compositions and methods
09/19/1989US4868182 Enhancement of prazosin
09/19/1989US4868161 Antimitotic agent, buffer
09/19/1989US4867979 Antidiarrheal compositions and use thereof
09/14/1989DE3906883A1 Pharmaceutical product
09/13/1989EP0332346A2 Pharmaceutical combinations containing a piperidinylcyclopentylheptenoic acid derivative
09/12/1989US4866034 Refined detoxified endotoxin
09/12/1989CA1259260A1 Synergistic combination of flupirtin and non- steriodal antiphlogistics
09/06/1989EP0331609A2 Angiotensin converting enzyme inhibitors having psychotropic effects
09/06/1989EP0331489A2 Acne treatment
09/06/1989EP0331391A1 Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
09/06/1989EP0331014A2 Use of ACE inhibitors in diabetes prophylaxis
09/05/1989US4863915 β-lactam antibiotics
09/05/1989US4863902 Treatment of cancer
09/05/1989US4863724 Anti-diabetic pharmaceutical compositions and the preparation thereof
08/1989
08/30/1989EP0330532A1 New galenic form of fenofibrate
08/30/1989EP0330358A2 Method of identifying whole cells having serine esterase activity
08/30/1989EP0330201A2 Method of enhancing the effect of cytotoxic agents
08/30/1989EP0329948A2 Use of beta-adrenergic blocking agents in the treatment of the progression of infantile myopia
08/29/1989US4861598 Higher aliphatic alcohol and acrylic resin
1 ... 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151